These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 7850928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro antitumor activity of a new platinum complex, cis-malonato [(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane] platinum (II) (SKI 2053R), against human lung and stomach cancer cell lines.
    Hong WS, Kim HT, Kim KH, Kim DK.
    Anticancer Res; 1995; 15(1):51-4. PubMed ID: 7733640
    [Abstract] [Full Text] [Related]

  • 4. Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) .
    Kim HT, Kim DK, Cho YB, Kim TS, Jung I, Kim KH, Heo DS, Bang YJ, Shin SG, Kim NK.
    Cancer Chemother Pharmacol; 1998; 41(2):109-16. PubMed ID: 9443623
    [Abstract] [Full Text] [Related]

  • 5. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK, Kim G, Gam J, Cho YB, Kim HT, Tai JH, Kim KH, Hong WS, Park JG.
    J Med Chem; 1994 May 13; 37(10):1471-85. PubMed ID: 8182706
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
    Cho YB, Kim KH, Kim DK.
    Drug Metab Dispos; 1995 Nov 13; 23(11):1280-5. PubMed ID: 8591731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Embryotoxic effects of SKI 2053R, a new potential anticancer agent, in rats.
    Chung MK, Kim JC, Roh JK.
    Reprod Toxicol; 1998 Nov 13; 12(3):375-81. PubMed ID: 9628560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in rats.
    Cho YB, Kim DK, Kim KH, Miyamoto G.
    Arzneimittelforschung; 1996 Jun 13; 46(6):629-34. PubMed ID: 8767356
    [Abstract] [Full Text] [Related]

  • 19. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E, Hrubisko M, Ujházy V.
    Neoplasma; 1984 Jun 13; 31(6):641-7. PubMed ID: 6395026
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M, Ohe Y, Kanzawa F, Oka M, Hara K, Saijo N.
    Anticancer Res; 1995 Jun 13; 15(2):393-8. PubMed ID: 7763011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.